Oocyte and ovarian tissue cryopreservation - Recent advances in oocyte and ovarian tissue cryopreservation
technology have brought hope not only to women facing premature loss of ovarian
function, but also to healthy women seeking delayed motherhood. This is a major
issue of contention in healthcare ethics. Proponents of this new technology
argue that this enables women to pursue educational and career goals in their
youth, so that they have greater financial security for children in later life.
Nevertheless, this argument may be flawed by the reality that even if the
cryopreservation of oocytes and ovarian tissue were optimized in the future,
this would in no way be a guaranteed route for women to have biological
children later in life.
The objective of this conference with the theme “The Ovary” is to
review and summarize the predictive ability of ovarian reserve markers, such as
antral follicle count (AFC) and anti-Mullerian hormone (AMH), and the
therapeutic strategies for ovarian stimulation, be it ovulation induction,
super ovulation or controlled ovarian stimulation.
Assessment of ovarian ageing and Dilemmas of
Ovarian stimulation - The main objective of individualization of treatment in ART is to
offer every single woman the best treatment tailored to her own unique
characteristics, thus maximizing the chances of pregnancy and eliminating the
iatrogenic and avoidable risks resulting from ovarian stimulation.
Personalization of treatment in IVF should be based on the prediction of
ovarian response for every individual. The starting point is to identify if a
woman is likely to have a normal, poor or a hyper response and choose the ideal
treatment protocol tailored to this prediction.
Endometriosis - The specific impact of
endometrioma alone and the impact of surgical intervention for
endometrioma on the reproductive outcome of women undergoing IVF/ICSI are
areas that require further clarification. The objectives of this conference
with regards to endometrioma are as follows: (i) to determine the impact
of endometrioma on IVF/ICSI outcomes, (ii) to determine the impact of
surgery for endometrioma on IVF/ICSI outcome and (iii) to determine
the effect of different surgical techniques on IVF/ICSI outcomes.
PCOS - Treatment of patients with polycystic ovary syndrome (PCOS) with
assisted reproductive techniques is a great challenge for the infertility
specialist. Patients with PCOS demonstrate many problems, such as excessive
body weight and hyperinsulinaemia, that render management more complex. In this
conference topics covered under PCOS include ‘Innovations in ovulation
induction (OI)’, ‘Treatment strategies in women who fails to conceive after 3
cycles of OI, Insulin resistance, Homocysteine and Pregnancy loss in PCOS : are
they related?
0 comments:
Post a Comment